“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: Risk factors associated with bladder cancer occurrence and recurrence: an epidemiological and clinical approach
Risk factors associated with bladder cancer occurrence and recurrence: an epidemiological and clinical approach
Reviews
There are no reviews yet.
Be the first to review “Article: Risk factors associated with bladder cancer occurrence and recurrence: an epidemiological and clinical approach” Cancel reply
Reviews
There are no reviews yet.